Safety and Efficacy of 6% Hydroxyethyl Starch (HES) Solution Versus an Electrolyte Solution in Patients Undergoing Elective Abdominal Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

2,289

Participants

Timeline

Start Date

September 28, 2017

Primary Completion Date

April 9, 2022

Study Completion Date

July 6, 2022

Conditions
Hypovolaemia Due to Acute Blood Loss
Interventions
DRUG

Volulyte 6%

Solution for infusion

DRUG

Ionolyte

Solution for infusion

Trial Locations (61)

Unknown

General Hospital of Barmherzige Brüder, Sankt Veit

Social Medical Center East - Donauspital, Vienna

Cliniques Universitaires Saint Luc, Brussels

AZ Maria Middelares, Ghent

Jessa Ziekenhuis, Hasselt

Clinical Hospital Sveti Duh, Zagreb

University Hospital Sisters of Mercy, Zagreb

University Hospital Zagreb, Zagreb

Kolín Hospital, Kolín

Central Military Hospital Prague, Prague

General University Hospital in Prague, Prague

University Hospital Motol, Prague

CHU Angers, Angers

Hospital Centre Pierre Oudot, Bourgoin

CHRU Lille, Lille

Hospital Centre Montauban, Montauban

Montpellier University Hospital, Montpellier

AP-HP Paris (Salpêtrière), Paris

Hospital Saint-Antoine, Paris

Hôpital Européen Georges Pompidou, Paris

University Hospital of Strasbourg, Strasbourg

Hospital Foch Suresnes, Suresnes

Hospital Jean Bernard, Valenciennes

Kliniken der Stadt Köln, Cologne

Carl-Thiem-Klinikum, Cottbus

Helios Amper-Klinikum, Dachau

Universitätsklinikum Carl Gustav Carus, Dresden

University Hospital Schleswig-Holstein Campus Kiel, Kiel

University Hospital Marburg, Marburg

University Hospital Munich, München

Universitätsklinikum Münster, Münster

Klinikum Oldenburg AÖR, Oldenburg

Regio Klinikum Pinneberg GmbH, Pinneberg

Amsterdam Medical Centre, Amsterdam

Martini General Hospital Groningen, Groningen

University Medical Center Groningen, Groningen

University Medical Center (UMC) Maastricht, Maastricht

University Clinical Center Gdansk, Gdansk

Szpital Specjalistyczny im. Św. Łukasza, Gmina Końskie

Medical University of Silesia, Katowice

Wojewodzki Szpital Zespolony, Konin

Jagiollonian University Hospital Medical College, Krakow

Medical University of Lublin, Lublin

Karol Marcinkowski Medical University in Poznań, Poznan

University Hospital in Wroclaw, Wroclaw

Klinika Wiśniowa, Zielona Góra

Fundeni Clinical Institute 1, Bucharest

Fundeni Clinical Institute 2, Bucharest

University Hospital Elias Bucharest, Bucharest

Emergency county hospital Cluj, Cluj-Napoca

Barcelona Clinic Hospital, Barcelona

Hospital Santa Creu i Sant Pau, Barcelona

University Hospital General Del Elche, Elche

Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria

Hospital Gregorio Marañon, Madrid

Hospital Ramón y Cajal, Madrid

Hospital Universitario Fundacion Alcorcon, Madrid

Quironsalud, Málaga

Hospital Clinico Universitario Valencia, Valencia

Hospital Universitari i Politecnic la Fe, Valencia

Hospital Universitario Rio Hortega, Valladolid

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

B. Braun Melsungen AG

INDUSTRY

collaborator

European Society of Anaesthesiology and Intensive Care

OTHER

lead

Fresenius Kabi

INDUSTRY

NCT03278548 - Safety and Efficacy of 6% Hydroxyethyl Starch (HES) Solution Versus an Electrolyte Solution in Patients Undergoing Elective Abdominal Surgery | Biotech Hunter | Biotech Hunter